Essais liés6clinical trials
VilleMemphislocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT04649242

Ouvrir le site du centre

Essais cliniques associés

6
MoléculeIndication / populationPhaseNCTTitreStatut
Rimegepant (PF-07899801) Migraine Phase 3 NCT04743141 Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine RECRUITING
ION337 Épilepsie Phase 1/2 NCT07531745 ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome RECRUITING
BHV-7000 Épilepsie Phase 2/3 NCT06309966 RISE 3 — Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy ACTIVE_NOT_RECRUITING
Clemizole HCl Épilepsie Phase 3 NCT04462770 ARGUS — A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome RECRUITING
Xcopri Épilepsie Phase 3 NCT05067634 Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures ACTIVE_NOT_RECRUITING
Rimegepant/BHV3000 Migraine Phase 3 NCT04649242 Randomized Study in Children and Adolescents With Migraine: Acute Treatment RECRUITING